ABOUT
SHUIMUBIO

We are at the golden age of structural biology. Our ambition is to explore new scientific boundaries in protein drugging possibilities by gathering top talent, technologies and ideas.

ShuimuBio is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China.

We are committed to drive change to empower drug discovery and accelerate the development of innovative drugs. To achieve this goal, we leverage the power of cutting-edge cryo-EM & AI technology to help our partners better understand the structures of the target proteins and complexes.

Meet the discoverers behind ShuimuBio’s
innovative breakthroughs.

We are partnering with a team of experts consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry.

Founders

Prof. Hongwei Wang

Founder丨Chairman of ShuimuBio Scientific Advisory Board

Prof. Qiangfeng Zhang

Founder丨Director of ShuimuBio Research Institute

Chunlong (Allen) Guo

Founder丨CEO

Scientific Advisory Board

Prof. Guangshuo Ou

Professor at School of Life Sciences, Tsinghua University. Committed to structural biology research based on nematode models.

Prof. Yifan Cheng

Professor at UCSF, Investigator of HHMI, Election to the AAAS and NAS. Developed direct electron detection camera in cryo-EM and significantly improved SPA resolution

Prof. Hai Qi

Dean of School of Medicine, Tsinghua University. Promoted the renewal and revision of Tfh generation mechanism and development theory.

Prof. Jianlin Lei

Director of Cryo-EM Platform at Tsinghua University. Developed automated data collection software AutoEMation.

Prof. Li Yu

Professor at School of Life Sciences, Tsinghua University. Discovered a new organelle Migrating Body

Prof. Xueming Li

Professor at School of Life Sciences, Tsinghua University. Expert in electron microscope and data processing.

ABOUT SHUIMUBIO